Richard D. Pilnik, Director at DiaMedica Therapeutics Inc. (DMAC), bought 19,000 shares at $2.80 ($53K) on 2019-05-31, disclosed to the SEC on 2019-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DMAC | BUY | 2021-08-17 | $49K | — | Filing → |
| DMAC | BUY | 2020-12-04 | $54K | — | Filing → |
| DMAC | BUY | 2019-08-19 | $20K | — | Filing → |